Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumor
Location: Fairfax VA, Margate FL
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06707610

Phase 1, Recruiting

Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04693468

Phase 1, Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

for
Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 50

Code: NCT03980769

Phase 2, Recruiting

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

for
Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05922501

Phase 2, Recruiting

Remote Temperature Monitoring of Patients At Risk for Developing Fever

for
Fever, Cancer, Remote Patient Monitoring
Location: Schenectady NY
Sponsor: AION Biosystems

Sex: All

Age: 18+

Code: NCT06752512

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06640010

Recruiting

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

for
Locally Advanced Malignant Solid Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04515810

Recruiting

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

for
Cancer
Location: Milwaukee WI
Sponsor: Sameem M. Abedin, MD

Sex: All

Age: 18+

Code: NCT05802069

Recruiting

A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced or Metastatic Solid Tumor Malignancies
Location: Bethesda MD
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT06258304

Phase 1, Recruiting

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06709404

Recruiting

Connect for Cancer Prevention Study (Connect)

for
Cancer, General Research Use
Location: Detroit MI, Atlanta GA, Marshfield WI, Minneapolis MN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 30 - 70

Code: NCT04609072

Recruiting

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

for
Cancer, Solid Tumor, Hematologic Malignancy
Location: Indianapolis IN, Martinsville IN
Sponsor: Community Cancer Care

Sex: All

Age: 18+

Code: NCT00300001

Recruiting

Correlates of CRCI and Gut Microbiome Dysbiosis; a Pilot Study

for
Cancer
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston

Sex: All

Age: 18+

Code: NCT06098404

Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

for
Hematologic Malignancy, Leukemia, Lymphoma,
Location: Philadelphia PA, Cincinnati OH, Milwaukee WI,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 38

Code: NCT06131801

Recruiting

Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies

for
Cancer, Radiotherapy Side Effect
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04115267

Recruiting

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

for
Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05039801

Phase 1, Recruiting

IDENTIFY Study: Natural History of Maternal Neoplasia

for
Maternal Neoplasia
Location: Bethesda MD
Sponsor: National Human Genome Research Institute (NHGRI)

Sex: Female

Age: 18 - 70+

Code: NCT04049604

Recruiting

Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)

for
Pediatric Cancer
Location: Chicago IL
Sponsor: Erin Rowell

Sex: Female

Age: 0 - 30

Code: NCT05309746

Recruiting

Informing Pain Treatment Using Pharmacogenomic Analysis

for
Adult Patients Who Are Receiving Oncologic Care
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06511401

Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Shirley NY, Lancaster PA, Binghamton NY, York PA,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial